Key Biscayne, FL, United States of America

Roland Jurecic

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Amgen Inc., Baylor College of Medicine, University of Miami. Active years: 2005-2007.

USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Roland Jurecic: Innovator in Phosphatase Research

Introduction

Roland Jurecic is a notable inventor based in Key Biscayne, FL (US). He has made significant contributions to the field of biochemistry, particularly in the area of phosphatases that activate MAP kinase pathways. With a total of 3 patents to his name, Jurecic's work has implications for the diagnosis and treatment of various diseases.

Latest Patents

Jurecic's latest patents focus on novel JNK activating phosphatase polypeptides and the nucleic acid molecules that encode them. These inventions provide vectors, host cells, antibodies, and methods for producing JNK activating phosphatase polypeptides. Additionally, they offer methods for diagnosing and treating diseases associated with these polypeptides.

Career Highlights

Throughout his career, Jurecic has worked with prominent organizations such as Amgen Inc. and Baylor College of Medicine. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.

Collaborations

Some of Jurecic's notable coworkers include Alice J Chen and Tse-Hua Tan. Their collaborative efforts have further enriched the research landscape in which Jurecic operates.

Conclusion

Roland Jurecic's innovative work in phosphatase research highlights his role as a key inventor in the field. His contributions continue to pave the way for advancements in medical diagnostics and treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…